Request To Download Free Sample of This Strategic Report @ Catalysts of Market Growth: The buoyant growth trajectory of the global monoclonal antibodies market is propelled by a convergence of ...

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, Jan. 10, 2025 /PRNewswire/ -- Harbour BioMed (HKEX: 02142, the ...

Thanks to an innovative method of super-resolution microscopy, researchers observed with molecular resolution in 3D how therapeutic antibodies attack and alter B cells, thereby inducing their ...

CTIM-76 Phase 1 trial focused on CLDN6-positive gynecologic and testicular cancers Trial marks key milestone in driving pipeline progress PHILADELPHIA, Jan. 14, 2025 (GLOBE NEWSWIRE) -- Context Therap ...

In blood cancers such as chronic lymphocytic leukemia, B cells of the immune system multiply uncontrollably. One form of ...

Eli Lilly partnership aims to identify new treatments for ALS based on antibodies from people with very slow disease ...

LAT-010 is under clinical development by Latticon Antibody Therapeutics and currently in Phase II for Ovarian Cancer.

Alloy Therapeutics ("Alloy"), a biotechnology ecosystem company dedicated to democratizing access to cutting edge drug ...

Orion Corporation ("Orion”) and Abilita Therapeutics ("Abilita”) announced today that they have entered into a research collaboration and option to license agreement to develop innovative antibody ...

Invenra has launched its Rapid Antibody Discovery Service, designed to simplify and de-risk the preclinical development of ...

AppClone announced on the 24th that it has developed the antibody therapeutic platform "mRMab" by merging messenger ribonucleic acid (mRNA) technology with existing antibody discovery technology.